[{"address1": "100 Campus Drive", "city": "Florham Park", "state": "NJ", "zip": "07932", "country": "United States", "phone": "608 441 8120", "website": "https://www.cellectar.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.", "fullTimeEmployees": 20, "companyOfficers": [{"maxAge": 1, "name": "Mr. James V. Caruso", "age": 64, "title": "President, CEO & Director", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 1142418, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chad J. Kolean CPA", "age": 59, "title": "VP, CFO & Secretary", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 711230, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jarrod  Longcor", "age": 50, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 854242, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Darrell Shane Lea", "age": 49, "title": "Chief Commercial Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrei  Shustov M.D.", "age": 51, "title": "Senior Vice President of Medical", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.04, "open": 2.07, "dayLow": 2.02, "dayHigh": 2.07, "regularMarketPreviousClose": 2.04, "regularMarketOpen": 2.07, "regularMarketDayLow": 2.02, "regularMarketDayHigh": 2.07, "beta": 0.992, "forwardPE": -0.7173145, "volume": 138478, "regularMarketVolume": 138478, "averageVolume": 263509, "averageVolume10days": 217970, "averageDailyVolume10Day": 217970, "bid": 2.01, "ask": 2.04, "bidSize": 300, "askSize": 400, "marketCap": 82349992, "fiftyTwoWeekLow": 1.82, "fiftyTwoWeekHigh": 4.45, "fiftyDayAverage": 2.0938, "twoHundredDayAverage": 2.86755, "currency": "USD", "enterpriseValue": 66237640, "floatShares": 29602617, "sharesOutstanding": 40566500, "sharesShort": 1959257, "sharesShortPriorMonth": 1615205, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.0547, "heldPercentInsiders": 0.02839, "heldPercentInstitutions": 0.31044, "shortRatio": 8.73, "shortPercentOfFloat": 0.062, "impliedSharesOutstanding": 35848900, "bookValue": 0.127, "priceToBook": 15.984251, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -48175740, "trailingEps": -2.43, "forwardEps": -2.83, "lastSplitFactor": "1:10", "lastSplitDate": 1658448000, "enterpriseToEbitda": -1.397, "52WeekChange": -0.18473893, "SandP52WeekChange": 0.31214523, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CLRB", "underlyingSymbol": "CLRB", "shortName": "Cellectar Biosciences, Inc.", "longName": "Cellectar Biosciences, Inc.", "firstTradeDateEpochUtc": 1131633000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "d92a6d57-8c29-3e38-89dc-584b57cac7f0", "messageBoardId": "finmb_37613299", "gmtOffSetMilliseconds": -18000000, "currentPrice": 2.03, "targetHighPrice": 25.0, "targetLowPrice": 4.0, "targetMeanPrice": 12.6, "targetMedianPrice": 12.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 25868908, "totalCashPerShare": 0.638, "ebitda": -47400856, "totalDebt": 530856, "quickRatio": 1.705, "currentRatio": 1.84, "debtToEquity": 3.857, "returnOnAssets": -1.65998, "returnOnEquity": -7.24666, "freeCashflow": -20477556, "operatingCashflow": -45166224, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-04"}]